missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Mouse Olfactomedin-1 ELISA Kit
Click to view available options
Quantity:
10 x 96 Tests
5 x 96 Tests
96 Tests
Unit Size:
Each
Pack of 10
Pack of 96
Description
Mouse Olfactomedin-1 quantitates mouse Olfactomedin-1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant mouse Olfactomedin-1.
The Olfactomedin family comprises a diverse group of secreted glycoproteins, which includes OLFM1 (Noelin-1), OLFM2 (Noelin-2), OLFM3 (Noelin-3), OLFM4 (Noelin-4), tiarin, pancortin, gliomedin and mycocilin. These proteins are implicated in the development of the nervous system. Specifically, OLFM1 and OLFM2 expression is observed in the neural plate and neural crest, as well as in the cranial ganglia in mouse at E8-10, and later in brain tissue and in the zone of polarizing activity in the limb. Overexpression of OLFM1 causes an excess of neural crest emigrations and prolonged neural crest production. OLFM2 participates in the regulation of the development of the anterior nervous system. An Arg144Gln mutation in OLFM2 has been implicated as a possible cause for open-angle glaucoma (OAG).
Specifications
Specifications
| Accession Number | 1B426B; AMY; AW742568; D2Sut1e; neuroblastoma protein; neuronal olfactomedin-related ER localized protein; Noe1; Noel; NOEL1; noelin; Noelin 1; Noelin 2; NOELIN1; OlfA; olfactomedin 1; olfactomedin related ER localized protein; olfactomedin-1; OLFM1; pancortin; pancortin 1; Pancortin 1-4; Pancortin3 |
| Assay Range | 0.084 to 20 ng/mL |
| Assay Sensitivity | 0.084 ng/mL |
| Conjugate | HRP |
| Product Type | ELISA |
| Sample Type | Plasma, Serum, Supernatant |
| For Use With (Equipment) | Colorimetric Microplate Reader |
| Gene ID (Entrez) | 56177 |
| Gene Symbol | OLFM1 |
| Interassay CV | <12% |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction